OrganoTherapeutics Company

OrganoTherapeutics use mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease.

Last Funding Type: Non-equity Assistance
Headquarters: Esch-sur-alzette, Luxembourg, Luxembourg
Founded Date: 2019-01-01
Last Funding Date: 2020-10-21
Employee Number: 1-10
Investors Number: 2.0
Industry: Clinical Development